glp-1 patent Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. π Demand for weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite pharmaindustry #glp1 #patentcliff #obesitytreatment #diabetescare
Pay in 4 interest-free payments of $5.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 28 - Sep 2























